Bright Minds Biosciences Inc.
DRUG · NASDAQ
9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Market Cap | $7 | $8 | $21 | $81 |
| - Cash | $6 | $7 | $12 | $20 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $10 | $61 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | $0 | -$7 | -$15 | $0 |
| % Margin | – | – | – | – |
| Net Income | -$3 | -$7 | -$15 | -$9 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.65 | -1.98 | -6.15 | -4.74 |
| % Growth | 67.2% | 67.8% | -29.7% | – |
| Operating Cash Flow | -$2 | -$7 | -$14 | -$7 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$2 | -$7 | -$14 | -$7 |